Please log in to view this page
Username
Password
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
